ACTIVATION OF CD4 CELLS BY FIBRONECTIN AND ANTI-CD3 ANTIBODY - A SYNERGISTIC EFFECT MEDIATED BY THE VLA-5 FIBRONECTIN RECEPTOR COMPLEX

被引:330
|
作者
MATSUYAMA, T
YAMADA, A
KAY, J
YAMADA, KM
AKIYAMA, SK
SCHLOSSMAN, SF
MORIMOTO, C
机构
[1] HARVARD UNIV,SCH MED,DANA FARBER CANC INST,DIV TUMOR IMMUNOL,BOSTON,MA 02115
[2] BRIGHAM & WOMENS HOSP,DEPT RHEUMATOL & IMMUNOL,BOSTON,MA 02115
[3] HARVARD UNIV,SCH MED,DEPT MED,BOSTON,MA 02115
[4] NCI,MOLEC BIOL LAB,MEMBRANE BIOCHEM LAB,BETHESDA,MD 20894
[5] HOWARD UNIV,CTR CANC,DEPT BIOCHEM,WASHINGTON,DC 20060
[6] HOWARD UNIV,CTR CANC,DEPT ONCOL,WASHINGTON,DC 20060
来源
JOURNAL OF EXPERIMENTAL MEDICINE | 1989年 / 170卷 / 04期
关键词
D O I
10.1084/jem.170.4.1133
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:1133 / 1148
页数:16
相关论文
共 50 条
  • [31] Receptor-mediated gene delivery to human peripheral blood mononuclear cells using anti-CD3 antibody coupled to polyethylenimine
    MM O'Neill
    CA Kennedy
    RW Barton
    RJ Tatake
    Gene Therapy, 2001, 8 : 362 - 368
  • [32] CYTOCHALASINS ENHANCE THE PROLIFERATION OF CD4 CELLS THROUGH THE CD3-TI ANTIGEN RECEPTOR COMPLEX OR THE CD2 MOLECULE THROUGH AN EFFECT ON EARLY EVENTS OF ACTIVATION
    MATSUYAMA, T
    YAMADA, A
    DEUSCH, K
    SLEASMAN, J
    DALEY, JF
    TORIMOTO, Y
    ABE, T
    JOURNAL OF IMMUNOLOGY, 1991, 146 (11): : 3736 - 3741
  • [33] Anti-CD3 inhibits circulatory and tissue-resident memory CD4 T cells that drive asthma exacerbations in mice
    Sethi, Gurupreet S. S.
    Gracias, Donald T. T.
    Gupta, Rinkesh K. K.
    Carr, Daniel
    Miki, Haruka
    Da Silva Antunes, Ricardo
    Croft, Michael
    ALLERGY, 2023, 78 (08) : 2168 - 2180
  • [34] ANTI-CD3 - ANTI-IL-2 RECEPTOR (CD3,25) BISPECIFIC MONOCLONAL-ANTIBODY (BSMAB) - T-CELL IMMUNOMODULATION WITH REDUCED ACTIVATION AND TOXICITY THAN ANTI-CD3 MAB INVIVO
    MACLEAN, JA
    SU, Z
    COLVIN, RB
    WONG, JT
    JOURNAL OF IMMUNOLOGY, 1993, 150 (08): : A189 - A189
  • [35] INHIBITION OF ANTI-CD3 (T3) ANTIBODY-INDUCED ACTIVATION OF T-CELLS BY CYCLOSPORINE
    BENTIN, J
    CARSON, DA
    VAUGHAN, JH
    TSOUKAS, CD
    TRANSPLANTATION, 1986, 42 (03) : 317 - 320
  • [36] Synergistic induction of CD154/CD40 ligand expression on human CD4+T cells by the combination of anti-CD3 and-CD4 stimulation.
    Fayen, JD
    Tykocinski, ML
    FASEB JOURNAL, 1999, 13 (04): : A626 - A626
  • [37] Activation of resting T cells against the CA 72-4 tumor antigen with an anti-CD3/CA 72-4 bispecific antibody in combination with a costimulatory anti-CD28 antibody
    Hombach, A
    Mathas, S
    Jensen, M
    Tillmann, T
    Menges, M
    Diehl, V
    Kruis, W
    Pohl, C
    ANTICANCER RESEARCH, 1997, 17 (3C) : 2025 - 2032
  • [38] BINDING OF ANTI-CD3, CD4, AND CD8 LIGANDS TO HUMAN LYMPHOCYTES-T INDUCES ASSOCIATION OF THE LIGAND-RECEPTOR COMPLEXES TO THE CYTOSKELETON
    THEODORE, AC
    CRUIKSHANK, WW
    CLINICAL RESEARCH, 1990, 38 (02): : A232 - A232
  • [39] Effect of interleukin-15 on effector and regulatory function of anti-CD3/anti-CD28-stimulated CD4+ T cells
    Lin, SJ
    Cheng, PJ
    Hsiao, SS
    BONE MARROW TRANSPLANTATION, 2006, 37 (09) : 881 - 887
  • [40] Transient chemokine production and antiviral effect in anti-CD3 and anti-CD28 activated monkey CD4+ T cells.
    Brice, GT
    Bostik, P
    Mayne, A
    Villinger, F
    Ansari, AA
    FASEB JOURNAL, 1998, 12 (04): : A295 - A295